Prediction of CYP-Mediated Drug Interaction Using Physiologically Based Pharmacokinetic Modeling: A Case Study of Salbutamol and Fluvoxamine

Drug–drug interactions (DDIs) represent a significant concern in healthcare, particularly for patients undergoing polytherapy. DDIs can lead to a range of outcomes, from decreased therapeutic effectiveness to adverse effects. Salbutamol, a bronchodilator recommended for the treatment of respiratory...

Descripción completa

Detalles Bibliográficos
Autores principales: Marques, Lara, Vale, Nuno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301358/
https://www.ncbi.nlm.nih.gov/pubmed/37376035
http://dx.doi.org/10.3390/pharmaceutics15061586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301358/
https://www.ncbi.nlm.nih.gov/pubmed/37376035
http://dx.doi.org/10.3390/pharmaceutics15061586

Ejemplares similares